We only have this paper's title and publication details.
Read it at the sourceInhibition of MTAP enhances tumor cell sensitivity to DRP-104, suggesting treatment potential under purine shortage.
Inhibiting MTAP sensitizes tumor cells to DRP-104 treatments.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: